Tirzepatide
US$ 28.83
glp 1 drug companies stock 3 at the Forefront of the GLP-1 Pill Wars GLP-1 Receptor Agonist Market Size
Description
[DOI] [PubMed] [Google Scholar] 123.Ji L, Jiang H, Cheng Z, et al
While Type 2 diabetes accounts for the majority of diabetes cases worldwide, the incidence of Type 1 diabetes is also increasing at an alarming rate
In the human body, the PLG polymers slowly degrade through the non-catalyzed hydrolysis of the ester linkages into lactic acid and glycolic acid, which are finally eliminated as carbon dioxide and water
Can GLP-1 be used in type 1 diabetes
This was an intercept-only model that corresponded to simple descriptive statistics and did not include any explanatory variables
